The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus | Zendy

Alexander Breskin | Zendy; Daniel Westreich | Zendy; Stephen R. Cole | Zendy; Michael G. Hudgens | Zendy; Christopher B. Hurt | Zendy; Eric C. Seaberg | Zendy; Chloe L. Thio | Zendy; Phyllis C. Tien | Zendy; Adaora A. Adimora | Zendy

Open Access

The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus

Author(s) -

Alexander Breskin,

Daniel Westreich,

Stephen R. Cole,

Michael G. Hudgens,

Christopher B. Hurt,

Eric C. Seaberg,

Chloe L. Thio,

Phyllis C. Tien,

Adaora A. Adimora

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy588

Subject(s) - medicine , hepatitis c , hepatitis c virus , confidence interval , cohort , cohort study , multicenter aids cohort study , immunology , risk factor , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , virus

Persons living with human immunodeficiency virus (HIV; PLwH) are commonly co-infected with hepatitis C virus (HCV). Most co-infected individuals can achieve a sustained HCV virologic response after treatment with direct-acting antivirals (DAA). However, the effect of HCV co-infection and DAA treatment on mortality after initiating antiretroviral therapy (ART) is unknown for PLwH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research